Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2005 | |
| Cash Flows From Operating Activities | |
| Net Income | -334 |
| Depreciation Amortization | 39 |
| Other Working Capital | 151 |
| Operating Cash Flow | $-144 |
| Cash Flows From Investing Activities | |
| Investing Cash Flow | $N/A |
| Cash Flows From Financing Activities | |
| Debt Issued | 207 |
| Debt Repayment | -4 |
| Common Stock Issued | 403 |
| Financing Cash Flow | $607 |
| Beginning Cash Position | 39 |
| End Cash Position | 502 |
| Net Cash Flow | $463 |
| Free Cash Flow | |
| Operating Cash Flow | -144 |
| Free Cash Flow | -144 |